Stay updated on Ivermectin in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.

Latest updates to the Ivermectin in Severe COVID-19 Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The change appears to be a metadata version bump rather than a substantive edit to study results.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; no other content changes were detected.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; the change appears to be limited to metadata with no visible changes to content or layout, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded a glossary toggle and QC metadata entries (First Submitted that Met QC Criteria, Results First Submitted that Met QC Criteria, Last Update Submitted that Met QC Criteria). Updated the revision to v3.4.0 and removed the previous v3.3.4 entry.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows a new revision label: v3.3.4, replacing the previous v3.3.3. There are no visible changes to study data, results, or page navigation.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision: v3.3.3 has been added; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.0%

Stay in the know with updates to Ivermectin in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.